[{"address1": "6310 Nancy Ridge Drive", "address2": "Suite 101", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 752 6170", "website": "https://www.cidara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.", "fullTimeEmployees": 38, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeffrey L. Stein Ph.D.", "age": 69, "title": "President, CEO & Executive Director", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 1098550, "exercisedValue": 0, "unexercisedValue": 1185968}, {"maxAge": 1, "name": "Dr. Leslie  Tari Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 688050, "exercisedValue": 0, "unexercisedValue": 323002}, {"maxAge": 1, "name": "Dr. Kevin M. Forrest Ph.D.", "age": 47, "title": "Founder & Chief Strategy Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 333313, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frank L. Karbe M.B.A.", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shane M. Ward J.D.", "age": 49, "title": "COO & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 620940, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preetam  Shah M.B.A., Ph.D.", "age": 51, "title": "Principal Accounting Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 577850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison  Lewis CCP, SPHR", "title": "Senior Vice President of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nicole  Davarpanah J.D., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Beitel M.B.A.", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Corrina  Pavetto", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 102.02, "open": 99.0, "dayLow": 98.45, "dayHigh": 103.02, "regularMarketPreviousClose": 102.02, "regularMarketOpen": 99.0, "regularMarketDayLow": 98.45, "regularMarketDayHigh": 103.02, "payoutRatio": 0.0, "beta": 1.338, "forwardPE": -12.998719, "volume": 764171, "regularMarketVolume": 764171, "averageVolume": 766065, "averageVolume10days": 995480, "averageDailyVolume10Day": 995480, "bid": 73.98, "ask": 127.1, "bidSize": 2, "askSize": 2, "marketCap": 2574349312, "fiftyTwoWeekLow": 11.07, "fiftyTwoWeekHigh": 121.21, "allTimeHigh": 382.6, "allTimeLow": 8.0, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 77.9406, "twoHundredDayAverage": 41.4364, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2066107392, "profitMargins": 0.0, "floatShares": 18784991, "sharesOutstanding": 25358051, "sharesShort": 3046157, "sharesShortPriorMonth": 2150846, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1201, "heldPercentInsiders": 0.00887, "heldPercentInstitutions": 1.07329, "shortRatio": 2.93, "shortPercentOfFloat": 0.12020001, "impliedSharesOutstanding": 25358051, "bookValue": 21.57, "priceToBook": 4.706537, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -117102000, "trailingEps": -7.63, "forwardEps": -7.81, "lastSplitFactor": "1:20", "lastSplitDate": 1713916800, "enterpriseToEbitda": -15.473, "52WeekChange": 8.048128, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 101.52, "targetHighPrice": 200.0, "targetLowPrice": 100.0, "targetMeanPrice": 159.57143, "targetMedianPrice": 167.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 510575008, "totalCashPerShare": 20.135, "ebitda": -133530000, "totalDebt": 2333000, "quickRatio": 15.856, "currentRatio": 16.455, "totalRevenue": 0, "debtToEquity": 0.466, "revenuePerShare": 0.0, "returnOnAssets": -0.23611, "returnOnEquity": -0.37050998, "grossProfits": -108720000, "freeCashflow": -100648248, "operatingCashflow": -129020000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CDTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.4901, "regularMarketPrice": 101.52, "shortName": "Cidara Therapeutics, Inc.", "longName": "Cidara Therapeutics, Inc.", "marketState": "CLOSED", "postMarketChangePercent": -0.325053, "postMarketPrice": 101.19, "postMarketChange": -0.329994, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1429104600000, "corporateActions": [], "postMarketTime": 1760745462, "regularMarketTime": 1760731201, "exchange": "NCM", "messageBoardId": "finmb_266264552", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -0.5, "regularMarketDayRange": "98.45 - 103.02", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 766065, "fiftyTwoWeekLowChange": 90.45, "fiftyTwoWeekLowChangePercent": 8.170732, "fiftyTwoWeekRange": "11.07 - 121.21", "fiftyTwoWeekHighChange": -19.690002, "fiftyTwoWeekHighChangePercent": -0.16244537, "fiftyTwoWeekChangePercent": 804.8128, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -7.63, "epsForward": -7.81, "epsCurrentYear": -5.84221, "priceEpsCurrentYear": -17.376986, "fiftyDayAverageChange": 23.5794, "fiftyDayAverageChangePercent": 0.30253038, "twoHundredDayAverageChange": 60.083595, "twoHundredDayAverageChangePercent": 1.4500196, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "displayName": "Cidara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]